Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Why LiveWire Ergogenics Inc. (LVVV) Is ‘One to Watch’

LiveWire Ergogenics (OTC: LVVV) is a forward-thinking company specializing in finding and monetizing present and upcoming trends in the health and wellness industry. An article discussing the company reads, “LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.”

To view the full article, visit http://cnw.fm/L2Zpv

About LiveWire Ergogenics Inc.

LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the human and veterinarian health and wellness industry. The company is focused on acquiring, managing and licensing specialized “closed loop” turnkey cannabis real estate locations of fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California and the state-wide distribution of these products. This includes verification of zero pesticide products for quality brands via its “7X Pure” Cannabis Verification System, and the development, licensing and distribution of legal, high-quality cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the United States Controlled Substance Act. For more information, visit the company’s website at www.LiveWireErgogenics.com.

NOTE TO INVESTORS: The latest news and updates relating to LVVV are available in the company’s newsroom at http://cnw.fm/LVVV

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Establishing Strong Position in Chinese CBD-Based Nutrition, Health-Product Market

ChineseInvestors.com (OTCQB: CIIX), a financial news and investment portal for the global Chinese-speaking community, is establishing itself as a major player in the emerging CBD market for CBD-based nutrition and health products in China. An article discussing the company reads, “Through wholly owned enterprise CBD Biotech Inc., CIIX is implementing its CBD initiatives. At present, CIIX is at the vanguard of what may become be the globe’s largest CBD market: China (www.CIIXInfo.com). The company recognizes the untapped CBD market for Chinese-speaking individuals, specifically in the health-care sector, which is expected to grow by as much as 10% per year. Due to a higher spending power from consumers, China’s demand for medicinal products such as those made from hemp-based CBD has risen. Analysts foresee China’s CBD market reaching over $20 billion by 2022, and CIIX is uniquely positioned to meet this consumer demand. CIIX is hoping for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020.”

To view the full article, visit http://cnw.fm/M0My1

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDNewsBreaks – VPR Brands LP (VPRB) Prepares to Launch Two New CBD Websites

Fort Lauderdale, Florida-based VPR Brands (OTCQB: VPRB), a multivertical, tiered, technology holding company, is moving its focus toward CBD as it gets ready to launch two new CBD brands websites: www.DrGoodHemp.com and www.CBDBrandDepot.com. An article discussing the company reads, “With its strong strategy of continually adding quality products and distribution designed to grow sales, VPR’s increasing customer base portends well for its CBD initiatives as the company offers a diverse portfolio of innovative products. . . . VPR Brands nurtures brands by way of direct sales and licensing opportunities in the CBD vertical. The company’s in-house product development is a significant differentiator, allowing VPRB to expand its margins (http://cnw.fm/X7nmH). VPR’s flagship CBD line, GoldLine, provides a broad product portfolio with offerings that include pre-rolled joints, vape cartridges, edibles, CBD pens, and crumble as well as tinctures.”

To view the full article, visit http://cnw.fm/GP9r3

About VPR Brands LP

VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical-marijuana vaporizers and electronic-cigarette products and components. The company is also engaged in product development for the vapor or vaping market including e-liquids. Vaporizers and electronic cigarettes, also known as e-cigarettes, are devices that deliver nicotine and/or cannabis through atomization or vaping without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Radicle Medical Marijuana Awarded Health Canada Oil License

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its portfolio company, Radicle Medical Marijuana Inc., has received approval for oil sales from Health Canada. The additional license allows for the development and sale of new cannabis products, including oil and concentrates, which will open the door for Radicle’s medical patients to access other product forms in the company’s craft cannabis selection. “Consumer behaviors are evolving, and we believe many of today’s cannabis consumers are open to trying alternatives to dried flower products,” Canopy Rivers President and CEO Narbé Alexandrian said in the news release. “With its Health Canada approval for the sale of formulated oil products, Radicle is well positioned to capitalize on this demand while maintaining its commitment to the production of premium, small-batch craft cannabis.”

To view the full press release, visit http://cnw.fm/z4Pyq

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Applauds FDA Forward-Looking Decision on Reduced Risk Tobacco Format

Global innovator in drug delivery platforms Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced that the Food and Drug Administration (“FDA”), for the first time ever, has authorized the marketing of oral nicotine products through the Modified Risk Tobacco Product pathway. According to the update, this pathway includes product categories that could benefit from Lexaria’s technology. The FDA-authorized product format is in the tobacco pouch category, similar to a mini tea-bag that is held in the mouth from which the nicotine within is absorbed. Unlike chewing tobacco, there is no need to spit. Significantly, because there is no combustion, heating or vaporization of the tobacco pouch during use, as well as FDA-accepted scientific evidence that included long-term epidemiological studies in association with this approval, claims of a lower risk of mouth cancer, stroke, lung disease, heart disease, emphysema and chronic bronchitis than cigarettes are permitted by the FDA. “Lexaria applauds this informed and forward-looking decision by the FDA to recognize improvements in delivery formats that are being made by industry,” Lexaria Bioscience Corp. CEO Chris Bunka said in the news release. “Lexaria realized long ago that DehydraTECH(TM) could empower alternative nicotine product formats and as a result our delivery technology which is already patented in the U.S. and patent pending around the world for enhanced oral nicotine delivery.”

To view the full press releases, visit http://cnw.fm/F4Jh3

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug-delivery platforms. Its patented DehydraTECH(TM) drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Posts Q4 & Full Year Financial Results, Hosts Conference Call

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Wednesday reported its results for the fourth quarter and full year ended June 30, 2019. Among other highlights, GGBXF reported total revenue for fiscal 2019 of $15.7 million, as well as a 29% quarter-over-quarter increase in revenue for the three-month period ended June 30, 2019. The company is hosting a conference call and audio webcast today, October 24th at 8:30 AM ET featuring GGBXF CEO Peter Horvath and CFO Brian Logan. To join the call, dial (+1) 416 764 8609 for the local Toronto line, (+1) 778 383 7417 for the local Vancouver line, or (+1) 888 390 0605 for the North American toll-free line and use the conference ID 66844833. A replay will be accessible on the company’s investor relations website following the call. “In a short-time we have built a pathway to open up to 47 dispensaries in three key states and established the first, best and only vertical CBD distribution network in the country,” Green Growth Brands CEO Peter Horvath stated in the news release. “This foundation leverages our strengths of creating brands consumers love, building innovative product assortments and operating and growing retail at scale, quarter after quarter.”

For more information regarding the growth and trajectory of GGBXF, visit http://cnw.fm/kgUu0

To view the full press release, visit http://cnw.fm/8hRjw

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S. its CBD presence at ShopSeventhSense.com, in malls across the country, at DSW and Abercrombie & Fitch stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGB

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Two Studies Show Marijuana is Helping Patients Avoid Opioids

Two studies show that patients suffering from chronic pain are using marijuana instead of addictive pharmaceuticals to help them manage the pain.

The studies are an addition to the growing body of research on the importance of marijuana in the growing opioid crisis in the United States.

The first study, carried out by researchers from Florida International University, investigated if managing pain was the only reason people substituted opioids with marijuana. The study was published in the International Journal of Drug Policy. The researchers used data from the National Survey on Drug Use and Health when evaluating the likelihood of opioid consumption by people in states where medical marijuana is legal and where medical marijuana was not available.

The researchers used the following to evaluate the data, did the respondents use or abuse any pain relief medication in the past year, the states they resided in, and if medical cannabis was legal. They analyzed the surveyed data for the year 2015 through to 2017, which included 120,764 respondents.

The study authors concluded that an analysis of the data resulted in a multivariate logistics regression equation, which showed that a reduction in opioid usage is associated with the medical cannabis laws.

The study states that marijuana helped patients minimize their dependence on opioids significantly because in relieving pain, marijuana and opiates are on the same level; however, most patients prefer to use weed over opioids. The patient’s perception of the treatment and tolerance of the side effect is the basis of a successful treatment plan.

The second study was carried out by researchers from the San Francisco Veterans Affairs Medical Center, who asked direct questions to people on whether or not patients use medical marijuana instead of the prescribed painkillers. The study, which was published in PloS, surveyed 16,280 adults where the researchers asked participants to share information on their opioid and cannabis usage. They also asked them to note if there were any changes in the amount of opioids they used after using marijuana and why the patients substituted cannabis for opioid prescriptions.

Those who responded to the survey were more than half the number of participants, whereby 5% (486) said to have used marijuana and opioid in the past year, 43% used opioid daily, and 23% reported to have used marijuana in the past one month. The study also found that 41% of the respondents stopped or reduced their opioid consumption because of marijuana, 46% did not alter their opioid usage, and 8% increased their opioid intake.

The researchers also found that most Americans substituted marijuana for opioids, with 36% crediting it to better at pain management, 32% experienced fewer side effects, and 26% associated it to fewer withdrawal symptoms. Thirteen percent said the medicine was cheap, and the remaining thirteen percent said they used it due to social acceptance.

The two studies show the importance of mitigating opioid use and misuse when caring for patients. And, the Department of Health and Human Services (HHS) Pain Management Inter-Agency echoed the same sentiments earlier this year.

Analysts believe these findings are in line with what the cannabis industry, including actors like Youngevity International Inc. (NASDAQ: YGYI) and Therma Bright Inc. (TSX.V: THRM) (OTC: THBRF), has always known as the benefit of medical marijuana in taming the opioid crisis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Universities Start Offering Marijuana Certificates to Healthcare Professionals

Healthcare professionals can now get cannabis certification from two education institutions, Pacific College of Oriental Medicine and Oaksterdam University.

Pacific College of Oriental Medical is the first institution to be regionally-accredited to offer healthcare professionals with a Medical Cannabis Certificate. The college is also a leader in integrative healthcare education.

This term, the college is partnering with Oaksterdam University to offer bonus cannabis lectures to their students.

The cannabis curriculum has been contributed to by professionals in the marijuana sector, and this includes attorneys, academics, activists, farmers and entrepreneurs. Among those who will be teaching are Natalie Darves and Paul Armentano, who will be sharing their extensive knowledge on the genetics and pharmacology of marijuana.

The partnership between the two institutions shows how important cannabis education is and their role as thought-leaders in the medical field.

The collaboration between the institutions will help advance cannabis education while guiding the healthcare professionals on the safe and effective use of marijuana, said Malcolm Youngren, COO of Pacific College.

According to Carey Clark, Pacific College program Chair, patients should be handled with care by providing them with accurate information about drug interactions, methods of purchasing CBD medication, how to derive maximum relief from medical marijuana as well as the side effects.

The two lecturers will cover topics on cannabis genealogy and cannabis and CBD. Cannabis genealogy expounds on cannabis genetics, how they are sourced and stabilized, and the cannabis genetic pool origin. They will also cover future research of genetics, genome testing and standards of labelling.

The cannabis and CBD topics will also cover the plant’s therapeutic properties, methods of administration, and how they interact with the body. They will also discuss specific conditions surrounding the use of cannabis and cannabinoids.

Dave Sky Jone, the Executive Chancellor of Oaksterdam University, said they are thrilled to partner with Pacific College in educating their students on the benefits and method of using marijuana.

The two institutions are looking forward to future opportunities of educating the healthcare industry on the importance of cannabis and its interaction with the human endocannabinoid system.

Pacific College of Oriental Medicines is the largest school that is accredited to offer courses in Chinese medicine and Massage therapy, such as acupuncture, in the U.S. It was founded in 1986 in San Diego and has branches in New York City and Chicago. The college has 1300 onsite students and 500 online students.

Meanwhile, Oaksterdam University is the first marijuana college in the U.S. It was founded in 2007 and has over 40,000 alumni all over the world. It offers its students hands-on marijuana plant experience. The university is popular because of its expertise and leadership in the marijuana sector as it provides regulatory training on government and public affairs by availing the students with exceptional learning and networking opportunities.

No one would be blamed for thinking that marijuana companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Hemptown USA are excited that these two reputable institutions have started equipping healthcare professionals with the skills that the need to administer medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Subsidiary Drives Notable Q4 Revenues

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently reported impressive financial results in its FY2019 year-end report (http://cnw.fm/vQrj1). An article discussing the company reads, “The company pointed to its core recreational flower brand, 7ACRES, as key to its impressive revenue performance. Committed to providing enthusiasts with hand-crafted cannabis flower that delivers an uncompromised experience, revenue from 7ACRES grew 443 percent year-over-year, from $3.5 million in Q4 2018 to $19 million in Q4 2019, and 90 percent quarter-over-quarter, from $10 million in Q3 2019. . . . ‘Our positive adjusted EBITDA and significant revenue growth in the fourth quarter reflects the rapid scale of our 7ACRES business and continued strong sales pricing for our brands from the provinces as we transition our premium supply to recreational sales channels,’ Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release.”

To view the full article, visit http://cnw.fm/9JFje

About Supreme Cannabis Company

The Supreme Cannabis Company, Inc., is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. Supreme Cannabis’ portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco, a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada. Supreme trades as FIRE on the Toronto Stock Exchange (TSX: FIRE), SPRWF on the OTC Exchange in the United States (OTCQX: SPRWF) and 53S1 on the Frankfurt Stock Exchange (FRA: 53S1). Follow the company on Instagram, Twitter, Facebook and YouTube. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/FIRE 

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – CannabisNewsWire to Serve as Official Media Partner at USA CBD Expo Vegas

CannabisNewsWire (“CNW”), an information service specializing in cannabis-related news, today announced that it will serve as an official media partner at USA CBD Expo Vegas, the nation’s largest CBD and hemp event. The trade show, slated to take place at the Las Vegas Convention center from February 13–15, 2020, will feature the largest selection of CBD/hemp products yet. More than 300 vendors and 500 brands will showcase new and innovative offerings including edibles, tinctures, beverages, topicals, vapes, cosmetics, flowers, pet products and more. Throughout the event, industry experts will share insight and experience, with an agenda covering topics from health and fitness to investing and product development. “Our 5,000-plus partner network — including USA Today, International Business Times, MarketWatch, Apple News and many others — provides a powerful communication tool to raise the awareness of this amazing event,” CNW Director of Syndicated Communications Christopher Johnson said in the news release. “In addition, we reach out directly to cannabis enthusiasts, consumers, businesses and investors from diverse demographics through social media accounts in our 40-plus brand network. Furthermore, USA CBD Expo Vegas will be featured prominently on our conference events page at CBDWire, HempWireNews and CannabisNewsWire. Through our efforts, we are dedicated to attracting additional attendees for this premier event and are honored to collaborate directly with the USA CBD team.”

To view the full press release, visit http://cnw.fm/lwwN0

About USA CBD Expo

USA CBD Expo strives to create the best and largest CBD / Hemp event in the nation, to consistently bring the most innovative and best products/brands to businesses and consumers, to compress a rapidly expanding industry into one all-encompassing, premier event. For more information, visit www.USACBDExpo.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com